Original Article

You have full text access to this OnlineOpen article

Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35†

  1. Vickie L. Shavers Ph.D.1,‡,*,
  2. Linda C. Harlan Ph.D.1,
  3. Jennifer L. Stevens B.S.2

Article first published online: 18 DEC 2002

DOI: 10.1002/cncr.11051

Issue

Cancer

Cancer

Volume 97, Issue 1, pages 134–147, 1 January 2003

Additional Information

How to Cite

Shavers, V. L., Harlan, L. C. and Stevens, J. L. (2003), Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer, 97: 134–147. doi: 10.1002/cncr.11051

Author Information

  1. 1

    Applied Research Program, Health Service and Economics Branch, Division of Cancer Control and Population Science, National Cancer Institute, Bethesda, Maryland

  2. 2

    Information Management Systems, Silver Spring, Maryland

  1. ‡

    Fax (301) 434-3710

*Applied Research Program, Health Service and Economics Branch, Division of Cancer Control and Population Science, National Cancer Institute, 6130 Executive Boulevard, MSC-7344, EPN Room 4005, Bethesda, MD 20892-7344

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 18 DEC 2002
  2. Article first published online: 18 DEC 2002
  3. Manuscript Accepted: 7 AUG 2002
  4. Manuscript Revised: 2 AUG 2002
  5. Manuscript Received: 17 JUN 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (116K)

REFERENCES

  • 1
    American Cancer Society. Cancer facts and figures, 2002. Atlanta: American Cancer Society, Inc., 2002.
  • 2
    American Cancer Society. Breast cancer facts and figures, 2001–2002. Atlanta: American Cancer Society Inc., 2002.
  • 3
    Chung M, Chang HR, Bland I, Wanebo H. Younger women with breast cancer have a poorer prognosis than older women. Cancer. 1996; 77: 97–103.
    Direct Link:
  • 4
    Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST. Stage 0 to Stage III breast cancer in young women. J Am Coll Surg. 2000; 190: 523–529.
  • 5
    Bonnier P, Romain S, Charpin C, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer. 1995; 17: 138–144.
    Direct Link:
  • 6
    Kurtz JM, Spitalier JM, Amalric R, et al. Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys. 1988; 15: 271–276.
  • 7
    Gillett D, Kennedy C, Carmalt H. Breast cancer in young women. Aust NZ J Surg. 1997; 67: 761–764.
    Direct Link:
  • 8
    Fowble BL, Schultz DJ, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys. 1994; 30: 23–33.
  • 9
    Yildirim E, Dalgic T, Berberoglu U. Prognostic significance of young age in breast cancer. J Surg Oncol. 2000; 74: 267–272.
    Direct Link:
  • 10
    Molnar L, Besznyak I, Koves I. Cancer of the breast in young women. Acta Chir Hungary. 1995- 1996; 35: 5–11.
  • 11
    Chapuis L, Chessler C. Breast cancer before 36 years of age [abstract]. Helv Chir Acta. 1989; 55: 895–902.
  • 12
    Elmore JG. Breast cancer tumor characteristics in black and white women. Cancer. 1998; 83: 2509–2515.
    Direct Link:
  • 13
    RiesLAG, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review 1973–1998. Bethesda: National Cancer Institute, 2001.
  • 14
    Ellege RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705–712.
  • 15
    Brinton LA, Benichou J, Gammon MD, Brogran DR, Coates R, Schoenberg JB. Ethnicity and variation in breast cancer incidence. Int J Cancer. 1997; 73: 349–355.
    Direct Link:
  • 16
    Swanson GM, Lin C. Survival patterns among younger women with breast cancer: the effects of age, race, stage and treatment. J Natl Cancer Inst Mongr. 1994; 16: 69–77.
  • 17
    Charlson ME; Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987: 40: 373–383.
  • 18
    Surveillance, Epidemiology and End Results (SEER) Program. SEER public-use data (1973–1998) [released April 2001, based on the August 2000 submission]. Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2000.
  • 19
    SAS Institute. SAS version 8.5. Cary, NC: SAS Institute, Inc., 2001.
  • 20
    Research Triangle Institute. SUDAAN. Research Triangle Park, NC: Research Triangle Institute, 2001.
  • 21
    Park BW, Kim SI, Kim MH, Kim EK, Park SH, Lee KS. Clinical breast examination for screening of asymptomatic women: the importance of clinical breast examination for breast cancer detection. Yonsei Med J. 2000; 41: 312–318.
  • 22
    Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 2000; 53: 53–60.
  • 23
    Bennett IC, Freitas R Jr., Fentiman IS. Diagnosis of breast cancer in young women. Aust NZ J Surg. 1991; 61: 284–289.
    Direct Link:
  • 24
    Weiss HA, Brinton LA, Brogan D, et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer. 1996; 73: 1298–1305.
  • 25
    Phillips JM, Cohen MZ, Moses G. Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum. 1999; 26: 561–571.
  • 26
    Laws MB, Mayo SJ. The Latina Breast Cancer Control Study, year one: factors predicting screening mammography utilization by urban Latina women in Massachusetts. J Commun Health. 1998; 23: 251–267.
  • 27
    Chavez LR, Hubbell FA, Mishra SI, Valdez RB. The influence of fatalism on self-reported use of Papanicoloau smears. Am J Prev Med. 1997; 13: 418–424.
  • 28
    Mayo RM, Ureda JR, Parker VG. Importance of fatalism in understanding mammography screening. J Women Aging. 2001; 13: 57–72.
  • 29
    Powe BD. Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum. 1995; 22: 1355–1359.
  • 30
    Powe BD. Fatalism among elderly African Americans. Cancer Nurs. 1995; 18: 385–392.
  • 31
    Weinick RM. Experience of primary care by racial and ethnic groups [correspondence]. Med Care. 2000; 38: 447–448.
  • 32
    Tarone RE, Chu KC. The greater impact of menopause on ER− than ER+ breast cancer incidence: a possible explanation (United States). Cancer Causes Control. 2002; 13: 7–14.
  • 33
    Fodor J, Major T, Polgar C, Toth J, Nemeth G. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early stage breast cancer after breast conserving therapy [abstract]. Neoplasma. 2000; 47: 181–186.
  • 34
    de Csepel J, Tartter PI, Gajdos C. When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol. 2000; 74: 273–277.
    Direct Link:
  • 35
    Szelei-Stevens KA, Kuske RR, Yantsos VA, Cederbom GJ, Bolton JS, Fineberg BB. The influence of young age and positive family history of breast cancer on the prognosis of ductal cancer in situ treated by excision with or without radiation therapy or by mastectomy. Int J Radiat Oncol Biol Phys. 2000; 48: 943–949.
  • 36
    Kim SH, Simkovich-Heerdt A, Tran KN, Maclean B, Borgen PI. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg. 1998; 187: 94–95.
  • 37
    Bradley CJ, Given CW, Roberts C. Race, socioeconomic status and breast cancer. J Natl Cancer Inst. 2002; 94: 7: 490–496.
  • 38
    Young WW, Marks SM, Kohler SA, Hsu. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy. Med Care. 1996; 34: 1003–1017.
  • 39
    Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996; 88: 716–726.
View Full Article (HTML) Get PDF (116K)